References
- 중앙사회보험의료협의회 : 의료보험에 있어서 혁신적인 의료기술의 취급에 관한 방법에 대해 ( 療保における革新的な療技 術の取扱いにする考え方について) (2010).
- Kim, J. M. : Off-label use. Korean J. Insur. Med. 7, 157 (2012).
- Radley, D. C., Finkelstein, S. N. and Stafford, R. S. : Off-label prescribing among office-based physicians. Arch. Intern. Med. 166, 1021 (2006). https://doi.org/10.1001/archinte.166.9.1021
- Lindell-Osuagwu, L., Korhonen, M. J., Saano, S., Helin- Tanninen, M., Naaranlahti, T. and Kokki, H. : Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature. J. Clin. Pharm. Ther. 34, 277 (2009). https://doi.org/10.1111/j.1365-2710.2008.01005.x
- Turner, S. : Unregistered and off-label drug use in paediatric inpatients. Aust. J. Hosp. Pharm. 29, 265 (1999). https://doi.org/10.1002/jppr1999295265
- DTB : Prescribing unlicensed drugs or using drugs for unlicensed indications. Drug Ther. Bull. 30, 97 (1992).
- Chen, D. T., Wynia, M. K., Moloney, R. M. and Alexander, G. C. : U.S. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey. Pharmacoepidemiol Drug Saf. 18, 1094 (2009). https://doi.org/10.1002/pds.1825
- Shin, J.-Y., Jung, S.-Y. and Park, B.-J. : Off-label drug use and its implications for evidence-based decision making. J. Pharmacoepidemiol Risk Manage. 3, 1 (2010).
- Ufer, M., Kimland, E. and Bergman, U. : Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden. Pharmacoepidemiol Drug Saf. 13, 147 (2004). https://doi.org/10.1002/pds.858
- Cuzzolin, L., Atzei, A. and Fanos, V. : Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Expert. Opin Drug Saf. 5, 703 (2006). https://doi.org/10.1517/14740338.5.5.703
- 어윤호 : MBC '시사매거진 2580', 미 허가약품 '싸이토텍' 고발. 메디컬투데이 (2009). Available from http://www.mdtoday.co.kr/ mdtoday/index.html?no=102698&cate=&sub=&key= &word=&page=1 (accessed 2014. Apr. 7).
- 이탁순 : '테르부탈린' 제제 임부 대상 오프라벨 사용 금지. 데일리팜 (2011). Available from http://www.dailypharm.com/ Users/News/NewsView.html?ID=137164 (accessed 2014. Apr. 7).
- Stafford, R. S. : Regulating Off-Label Drug Use--Rethinking the Role of the FDA. N. Engl. J. Med. 358, 1427 (2008). https://doi.org/10.1056/NEJMp0802107
- 이탁순 : 오프라벨 효과 평가, 임의비급여 정리되나. 데일리팜 (2010). Available from http://www.dailypharm.com/Users/ News/NewsView.html?ID=122812 (accessed 2014. Apr. 7).
- 이탁순 : 오프라벨 사용지침 필요, 레이블 수시 교체해야. 데일리팜 (2011). Available from http://www.dailypharm.com/Users/ News/NewsView.html?ID=140518 (accessed 2014. Apr. 7).
- 이탁순 : 오프라벨 심사 '따로따로' 환자진료 혼란 초래. 데일리팜 (2011). Available from http://www.dailypharm.com/Users/ News/NewsView.html?ID=146430 (accessed 2014. Apr. 7).
- Korea Food & Drug Administration : 2010 list of FDA regulatory reforms. Seoul, Korea Food & Drug Administration (2010).
- Garattini, S. and Bertele', V. : The role of the EMEA in regulating pharmaceutical products. In: Mossialos E, Mrazek M, Walley T, eds., Regulating pharmaceuticals in Europe: striving for efficiency, equity and quality. Open University Press. Maidenhead. p. 80 (2004).
- MHRA : Drug safety update. (2011). Available from http:// www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/ CON087990 (accessed 2012. Jul. 30).
- General Medical Council : Good practice in prescribing medicines. General Medical Council (2008).
- NICE : Evidence summaries: unlicensed/off-label medicines. (2013). Available from http://www.nice.org.uk/mpc/ evidencesummariesunlicensedofflabelmedicines/ (2014. Jan. 27).
- Working group on paediatric medicines: Evaluation of the efficacy and safety of buspirone in children and adolescents aged <18 years. London, Medicines and Healthcare products Regulatory Agency (2004).
- European Commission : Guidelines on Pharmacovigilance for Medicinal Products for Human Use (2008).
- EMEA : Guideline on conduct of pharmacovigilance for medicines used by the paediatric population. London, European Medicines Agency, Committee for Medicinal Products for Human Use (2006).
- EURORDIS : EURORDIS response to the European Commission Public Consultation "Legal proposal on information to patients" (2008).
- Hampton, T. : Experts weigh in on promotion, prescription of off-label drugs. JAMA. 297, 683 (2007).
- U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation Research, Center for Veterinary MedicineandCenter for Devices and Radiological Health : Responding to unsolicited requests for off-label information about prescription drugs and medical devices (2011).
- Blue Cross Blue Shield : Off-Label Use of U.S. FDA Approved Drugs. (2013). Available from https://www.bcbsmt.com/ MedReview/Policies/OffLabelDrugUse/v102.aspx (accessed 2014. Jan. 29).
- AmeriHealth : Experimental/Investigational/Off-label drug use. Pharmacy Policy Bulletin. (2013). Available from http:// www.amerihealth.com/pdfs/providers/pharmacy_information/ pharmacy_policies/experimental_drug_use.pdf (accessed 2014. Jan. 29).
- Abernethy, A. P., Raman, G., Balk, E. M., Hammond, J. M., Orlando, L. A., Wheeler, J. L., Lau, J. and McCrory, D. C. : Systematic Review: Reliability of Compendia Methods for Off- Label Oncology Indications. Ann. Intern. Med. 150, 336 (2009). https://doi.org/10.7326/0003-4819-150-5-200903030-00107
- US FDA : FDA Adverse Event Reporting System (FAERS) Website (2012). Available from http://www.fda.gov/Drugs/ GuidanceComplianceRegulatoryInformation/Surveillance/ AdverseDrugEffects/default.htm (accessed 2014. Jan. 9).
- Weiss, B. D., Coyne, C., Michielutte, R., Davis, T. C., Meade, C. D., Doak, L. G., Cecilia, C. D., Brown, P., Askov, E., Mettger, W., Songer, T., Friedell, G. H. and Smith, T. : Communicating with patients who have limited literacy skills: Report of the National Work Group on Literacy and Health. J. Fam Pract. 46, 168 (1998).
- Coulter, A., Parsons, S. and Askham, J. : Where are the patients in decision-making about their own care? WHO European Ministerial Conference on Health Systems. Tallinn, Estonia (2008).
- Consumer Reports : "Off-Label" drug use. Shopper's guide to prescription durgs - number 6. (2007) Available from http:// www.consumerreports.org/health/resources/pdf/best-buydrugs/ money-saving-guides/english/Off-Label-FINAL.pdf (accessed 2012. Mar. 22).
- 가가와대학의학부 부속병원 : 적응외 사용(適外使用). (2008). Available from http://www.kms.ac.jp/-yakuzaib/CTMcenter/ outside/index.html (accessed 2012. Aug. 20).
- Palate, V. : The Impact of Off-Label, Compassionate and Unlicensed Use on Health Care Laws in preselected Countries. Bonn, Drug Regulatory Affairs, Rheinishe Friedrich-Wilhelms-University (2009).
- 보건후생노동성 : 의약품의 적응외사용에 관한 보험진료상의 취급에 대해 ( 品の適外使用に係る保診療上の取扱いについて ) (2010).
- Lee, S., Lee, I.-H., Lee, Y. S., Kye, S. and Seo, M. : Development of regulation system for evaluation of off-label drug use. College of Pharmacy, Ajou University, Korea Food & Drug Administration (2012).
- 보건후생노동성 : 미승인약, 적응외약의 해소를 위한 검토에 대해 (未承認.適外解消に向けての討について) (2011).
- 중앙제약단체연합회 : 약가제도개혁에 관현 의견( 制度改革に する意見) (2011).
- 중앙사회보험의료협의회 : 공지신청된 적응외약의 보험적용에 관해 (公知申₩請とされた適外の保適用について) (2010).
- Nakano, T. : Pharmaceutical laws and Regulations. Pharmaceutical administration and regulations in Japan, Japan Pharmaceutical Manufacturers Association (2010).
- 보건후생노동성 : 제약기업으로부터 의료기관에의 적응외사용 정보제공의 정리(平成21年度厚生勞動科學- 究費補助金 厚生勞動 科學特別硏究事業 分硏究報告書 3. 製藥企業から醫療機關への 適應外使用情報提供の整理). 후생노동과학특별연구사업 분담연구고서 (2009).
- Faculty of Pain Medicine ANZCA (FPM) : Use of "off label" or drugs beyond license in pain medicine. (2007). Available from http://www.fpm.anzca.edu.au/resources/educationaldocuments/ documents/use-of-off-label-drugs-or-beyondlicence/ (accessed 2012. Aug. 18).
- Gazarian, M., Kelly, M., McPhee, J. R., Graudins, L. V., Ward, R. L. and Campbell, T. J. : Off-label use of medicines: consensus recommendations for evaluating appropriateness. Med. J. Aust. 185, 544 (2006).
- NSW Department of Health : Off label use of registered medicines and use of medicines under the personal importation scheme in NSW public hospitals. (2003). Available from http://www.ciap.health.nsw.gov.au/nswtag/publications/ otherdocs/off_label_useregistered_medicines (accessed 2012. Aug. 2).
- Lee, S. M. : Evidence-based healthcare: Seeking for the broken virtuous circle. J. Korean Med. Association. 52, 532 (2009). https://doi.org/10.5124/jkma.2009.52.6.532